Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

NCT03623854 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chordoma
Locally Advanced Chordoma
Metastatic Chordoma
Unresectable Chordoma

Interventions

BIOLOGICAL: Nivolumab
BIOLOGICAL: Relatlimab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]